Study on the Susceptibility of Lncrna PCAT1 Snps and Breast Cancer Risk in the Chinese Population

The purpose of this study is to explore the relationship between PCAT1-SNPs and breast cancer (BC) susceptibility. Logistic regression analysis was applied to determine the association between PCAT1-SNPs and BC risk. The relative expression of PCAT1 in different genotypes was detected by qRT-PCR. The binding between the genotype of C/T at rs4473999 locus and miR-149-5p was confirmed by dual luciferase gene reporter assays. The proliferation, migration and invasion of BC cells with dysregulated expression of miR-149-5p was evaluated by CCK8, Scratch and Transwell assay, respectively. Logistic regression analysis revealed PCAT1-SNPs was related to the susceptibility of BC that rs117117537 (OR:2.413, 95%CI: 1.057–5.508) and rs4473999 (OR:2.137 95%CI: 1.065–4.286) were risk factors of BC when the menopausal age was ≥ 50; The haplotype Grs1551514Trs1551513Crs4473999Crs9656964Trs17762938Crs7823297Trs785003Trs117117537 may increase the risk of BC (OR:1.614 95%CI: 1.116–2.333), and there was an association between genes and reproductive factors (OR:2.487 95%CI: 1.929–3.206). Preliminary functional studies demonstrated that PCAT1 interacted with miR-149-5p when rs4473999 carried wild type C; In addition, the dysregulated enrichment of miR-149-5p may affect the proliferation, invasion and migration of BC cells. Our study shows that PCAT1 gene polymorphism is related to BC susceptibility, PCAT1-rs4473999 C/T genotype may affect the occurence of BC by modulating the interactions with miR-149-5p.

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  Liu Yang,et al.  circANKS1B regulates FOXM1 expression and promotes cell migration and invasion by functioning as a sponge of the miR-149 in colorectal cancer , 2019, OncoTargets and therapy.

[3]  Wei Wang,et al.  LIMK2 acts as an oncogene in bladder cancer and its functional SNP in the microRNA‐135a binding site affects bladder cancer risk , 2018, International journal of cancer.

[4]  Xi Luo,et al.  Long non-coding RNA CCAL/miR-149/FOXM1 axis promotes metastasis in gastric cancer , 2018, Cell Death & Disease.

[5]  Hailin Tang,et al.  Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a , 2018, Oncogene.

[6]  Kaijuan Wang,et al.  Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population. , 2018, Gene.

[7]  C. Peng,et al.  Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer , 2017, Molecular Cancer.

[8]  Fenghua Wang,et al.  Long non-coding RNA UICLM promotes colorectal cancer liver metastasis by acting as a ceRNA for microRNA-215 to regulate ZEB2 expression , 2017, Theranostics.

[9]  B. Fromm,et al.  Deciphering the function of non-coding RNAs in prostate cancer , 2016, Cancer and Metastasis Reviews.

[10]  A. Leo,et al.  Challenges in the management of advanced, ER-positive, HER2-negative breast cancer , 2015, Nature Reviews Clinical Oncology.

[11]  Feng Zhang,et al.  A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma , 2014, Cell Death and Disease.

[12]  Wanqing Chen,et al.  Breast cancer in China. , 2014, The Lancet. Oncology.

[13]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[14]  C. Peng,et al.  Ampli fi cation of Long Noncoding RNA ZFAS1 Promotes Metastasis in Hepatocellular Carcinoma , 2015 .